Beyond Palm Olein: Triacylglycerol Stereochemistry, Fat-Calcium Bioavailability, Gut Ecology, and Skeletal Development in Modern Infant Formula-A Critical Review

Abstract

Palm olein has long been used in infant formula to approximate the palmitic acid content of human milk, yet matching fatty-acid quantity does not reproduce human-milk triacylglycerol stereochemistry. In human milk, palmitate is preferentially esterified at the sn-2 position, whereas conventional vegetable-oil blends frequently position palmitate at sn-1 and sn-3. Pancreatic and gastrointestinal lipolysis can therefore release more free palmitic acid from conventional formulas, facilitating formation of poorly soluble calcium–fatty-acid soaps and potentially influencing lipid and calcium absorption, stool physiology, intestinal ecology, and skeletal mineralization. This critical qualitative literature review reassesses the palm-olein controversy in light of studies published predominantly during 2020-2026. Contemporary evidence indicates that increasing sn-2 palmitate consistently reduces fecal palmitate soaps and, in several studies, fecal calcium loss. However, effects on stool consistency, gastrointestinal tolerance, growth, microbiota, and bone outcomes are less uniform. Importantly, modern formulas increasingly incorporate structured lipids, dairy fat, milk-fat-globule-membrane components, phospholipid- coated lipid droplets, prebiotics, probiotics, and human-milk-oligosaccharide analogues. These innovations can modify physiological responses independently of palm olein. Emerging microbiome and metabolomic studies further suggest links among palmitate stereochemistry, fecal soaps, Bifidobacterium, intestinal pH, and microbial metabolism. The evidence therefore supports replacing a binary “palm-containing versus palm-free” framework with structure-based assessment of the complete formula lipid matrix.